Patten Group Has Raised Stake in Hanesbrands (HBI); Alder Biopharmaceuticals (ALDR) Shareholder Swiss National Bank Lifted Stake by $372,000 as Stock Declined

February 18, 2018 - By Richard Conner

Swiss National Bank increased its stake in Alder Biopharmaceuticals Inc (ALDR) by 46.73% based on its latest 2017Q3 regulatory filing with the SEC. Swiss National Bank bought 31,000 shares as the company’s stock declined 24.25% while stock markets rallied. The institutional investor held 97,342 shares of the health care company at the end of 2017Q3, valued at $1.19 million, up from 66,342 at the end of the previous reported quarter. Swiss National Bank who had been investing in Alder Biopharmaceuticals Inc for a number of months, seems to be bullish on the $919.27 million market cap company. The stock decreased 3.56% or $0.5 during the last trading session, reaching $13.55. About 1.23 million shares traded. Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR) has declined 33.67% since February 18, 2017 and is downtrending. It has underperformed by 50.37% the S&P500.

Patten Group Inc increased its stake in Hanesbrands Inc (HBI) by 1196.93% based on its latest 2017Q3 regulatory filing with the SEC. Patten Group Inc bought 56,495 shares as the company’s stock declined 1.43% while stock markets rallied. The institutional investor held 61,215 shares of the clothing and shoe and accessory stores company at the end of 2017Q3, valued at $1.51M, up from 4,720 at the end of the previous reported quarter. Patten Group Inc who had been investing in Hanesbrands Inc for a number of months, seems to be bullish on the $7.38 billion market cap company. The stock decreased 0.39% or $0.08 during the last trading session, reaching $20.49. About 4.76M shares traded. Hanesbrands Inc. (NYSE:HBI) has declined 23.23% since February 18, 2017 and is downtrending. It has underperformed by 39.93% the S&P500.

Patten Group Inc, which manages about $247.19 million US Long portfolio, decreased its stake in Qualcomm Inc (NASDAQ:QCOM) by 6,480 shares to 4,625 shares, valued at $240,000 in 2017Q3, according to the filing. It also reduced its holding in Starbucks Corp (NASDAQ:SBUX) by 6,979 shares in the quarter, leaving it with 12,372 shares, and cut its stake in At&T Inc (NYSE:T).

Investors sentiment decreased to 1.15 in 2017 Q3. Its down 0.18, from 1.33 in 2017Q2. It turned negative, as 43 investors sold HBI shares while 189 reduced holdings. 78 funds opened positions while 188 raised stakes. 334.65 million shares or 1.31% more from 330.33 million shares in 2017Q2 were reported. X Mngmt Limited Liability owns 10,445 shares for 0.01% of their portfolio. Old Mutual Customised Solutions (Proprietary) Ltd reported 15,300 shares or 0.05% of all its holdings. Guardian Life Insur Of America invested in 840 shares or 0% of the stock. Private Trust Co Na has 0.08% invested in Hanesbrands Inc. (NYSE:HBI). 30,677 are owned by Advisory Serv Network Llc. Fincl Service holds 1,109 shares or 0.01% of its portfolio. Mirae Asset Glob Investments reported 78,937 shares. Dnb Asset As accumulated 38,552 shares or 0.01% of the stock. Neuberger Berman Grp Inc Limited Liability reported 47,973 shares. Nomura Inc holds 18,523 shares. 348 are owned by Trust Of Vermont. Bb&T Corporation owns 0.3% invested in Hanesbrands Inc. (NYSE:HBI) for 622,807 shares. New Jersey-based Princeton Strategies Group Incorporated Lc has invested 1.67% in Hanesbrands Inc. (NYSE:HBI). Leavell Investment Mngmt Inc has invested 0.03% in Hanesbrands Inc. (NYSE:HBI). 1.06M are owned by Barclays Public Limited Liability Com.

Since August 28, 2017, it had 0 buys, and 1 sale for $250,536 activity.

Among 19 analysts covering Hanesbrands (NYSE:HBI), 11 have Buy rating, 0 Sell and 8 Hold. Therefore 58% are positive. Hanesbrands had 57 analyst reports since September 17, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Nomura given on Thursday, September 21. The company was upgraded on Friday, December 4 by Goldman Sachs. The firm has “Overweight” rating by Barclays Capital given on Thursday, November 2. The firm earned “Market Perform” rating on Wednesday, October 12 by Cowen & Co. Oppenheimer initiated the shares of HBI in report on Friday, October 16 with “Outperform” rating. UBS maintained Hanesbrands Inc. (NYSE:HBI) on Friday, February 3 with “Buy” rating. Stifel Nicolaus maintained it with “Hold” rating and $23.0 target in Monday, September 25 report. CL King upgraded the stock to “Buy” rating in Monday, December 12 report. Wells Fargo reinitiated the shares of HBI in report on Thursday, October 22 with “Outperform” rating. The firm has “Equal-Weight” rating given on Monday, February 27 by Morgan Stanley.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>